Drug Search Results
More Filters [+]

Sorbitan tristearate

Alternative Names: sorbitan tristearate
Latest Update: 2024-02-23
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Subcutaneous,Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: University of Auckland
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sorbitan tristearate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12619000390189

N/A

Recruiting

Dry Eye Disease|Keratoconjunctivitis Sicca

2019-10-30

ACTRN12619000361101

N/A

Recruiting

Keratoconjunctivitis Sicca|Dry Eye Disease

None

Recent News Events